… of coadministration of nirmatrelvir and ritonavir among vaccinated populations is uncertain.
This study emulated a clinical trial to assess whether nirmatrelvir plus ritonavir reduces risk …

… , medical history, healthcare access, … nirmatrelvir plus ritonavir prescription. To better achieve
exchangeability between patients prescribed and not prescribed nirmatrelvir plus ritonavir, …

… cases receiving nirmatrelvir-ritonavir in ambulatory care settings, … the effectiveness of
nirmatrelvir-ritonavir in preventing severe … testing within a large, integrated US healthcare system. …

… In the USA, oral nirmatrelvir–ritonavir is … of nirmatrelvir–ritonavir in preventing hospital
admissions and death in people with COVID-19 in an outpatient prescribing context in the USA. …

… a large US healthcare system to describe nirmatrelvir–ritonavir … National Institutes of Health
treatment eligibility criteria for the … -2 infections received nirmatrelvir–ritonavir over the study …

… data from the electronic health records of University of Colorado Health, the largest …
nirmatrelvir–ritonavir order. We propensity score matched patients treated with nirmatrelvir–ritonavir …

… Our study is among the first to describe real-world utilization of nirmatrelvir/ritonavir in a
large national cohort of outpatients with COVID-19 and to identify predictors of outpatient …

… study in a large US health-care system. … nirmatrelvir–ritonavir was dispensed had symptoms
for more than 5 days or were asymptomatic—populations in which nirmatrelvir–ritonavir has …

… demonstrated the effectiveness of nirmatrelvir; ritonavir in reducing … of using nirmatrelvir;
ritonavir in a high-risk US population infected … in a large US health system. Preprint. medRxiv. …

… nirmatrelvir/ritonavir real-world effectiveness in preventing hospitalization among high-risk
US … Study strengths include the large population-based design, which extracted data from a …